Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating
Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating
Truist将Corcept医疗的目标价调整为65美元,较之前的44美元上调,同时维持买入评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册